Beverley Patterson

Tadalafil pharmacokinetics in healthy subjects.

M. Mitchell, R. Wrishko, A. Bedding, 2006, British journal of clinical pharmacology.

Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics.

M. Mitchell, R. Wrishko, A. Bedding, 2007, British journal of clinical pharmacology.

Pharmacokinetics (PK) of single doses of mometasone furoate (MF) delivered via the Breezhaler® (BH) and Twisthaler® (TH) devices in healthy subjects

Thomas M. Smith, Baldur P Magnusson, U. Malmqvist, 2012 .

Effect of Tadalafil on Cytochrome P450 3A4–mediated Clearance: Studies in Vitro and in Vivo

J. Gillespie, B. Ring, S. Wrighton, 2005, Clinical pharmacology and therapeutics.